OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Astrocyte Pharmaceuticals Inc.

1 Projects | 1 Researchers | $1,000,000 Invested

2023

Astrocyte Pharmaceuticals Inc.

James Lechleiter, PhD

Development of AST-004 as a Treatment for Alzheimer’s Disease and Related Dementias

  • Funding Amount: $1,000,000
  • Organization Type: Biotechnology/For Profit
  • Program: Drug Discovery
  • Target: Neuronal Degeneration
  • Status: Active